CIK: 0001595851 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value: $426M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 850,000 | $72.14M | 16.9% | $84.87 | — | — | Put | 78464A870 |
| — | IMMUNOMEDICS INC | 1,538,000 | $24.85M | 5.8% | $16.16 | $7.08 | — | COM | 452907108 |
| — | IMMUNOMEDICS INC | 1,300,000 | $21.01M | 4.9% | $16.16 | $7.08 | — | Call | 452907108 |
| ARGX | ARGENX SE | 250,000 | $15.79M | 3.7% | $63.14 | $21.52 | — | SPONSORED ADR | 04016X101 |
| — | CELGENE CORP | 150,000 | $15.65M | 3.7% | $104.36 | — | — | Call | 151020104 |
| ESPR | ESPERION THERAPEUTICS INC NE | 230,000 | $15.14M | 3.6% | $65.84 * | $53.84 | 0.0% | COM | 29664W105 |
| — | ALEXION PHARMACEUTICALS INC | 115,000 | $13.75M | 3.2% | $119.59 | $121.40 | — | COM | 015351109 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 325,000 | $12.79M | 3.0% | $39.35 | $32.97 | — | COM | 37890U108 |
| — | ALLERGAN PLC | 75,000 | $12.27M | 2.9% | $163.59 | $163.58 | — | Call | G0177J108 |
| — | BLUEPRINT MEDICINES CORP | 150,000 | $11.31M | 2.7% | $75.41 | $75.41 | — | COM | 09627Y109 |
| — | PORTOLA PHARMACEUTICALS INC | 225,000 | $10.95M | 2.6% | $48.68 | $48.68 | — | COM | 737010108 |
| — | MIRATI THERAPEUTICS INC | 600,000 | $10.95M | 2.6% | $18.25 | $18.25 | — | COM | 60468T105 |
| — | MYLAN N V | 250,000 | $10.58M | 2.5% | $42.31 | $42.31 | — | SHS EURO | N59465109 |
| ASND | ASCENDIS PHARMA A S | 250,000 | $10.02M | 2.3% | $40.06 | $37.01 | — | SPONSORED ADR | 04351P101 |
| — | AVEXIS INC | 85,000 | $9.407M | 2.2% | $110.67 | $49.54 | — | COM | 05366U100 |
| BMY | BRISTOL MYERS SQUIBB CO | 150,000 | $9.192M | 2.2% | $61.28 * | $43.12 | +7.7% | Call | 110122108 |
| — | ACCELERON PHARMA INC | 200,000 | $8.488M | 2.0% | $42.44 | $34.51 | — | COM | 00434H108 |
| VRAYQ | VIEWRAY INC | 900,000 | $8.334M | 2.0% | $9.26 * | $6.99 | +14.6% | COM | 92672L107 |
| — | DBV TECHNOLOGIES S A | 325,000 | $7.995M | 1.9% | $24.60 | $35.76 | — | SPONSORED ADR | 23306J101 |
| — | ALLERGAN PLC | 45,750 | $7.484M | 1.8% | $163.58 | $163.58 | — | SHS | G0177J108 |
| — | ZOGENIX INC | 180,000 | $7.209M | 1.7% | $40.05 | $31.08 | — | COM NEW | 98978L204 |
| — | SAGE THERAPEUTICS INC | 43,700 | $7.198M | 1.7% | $164.71 | $164.69 | — | Put | 78667J108 |
| — | JUNO THERAPEUTICS INC | 150,000 | $6.857M | 1.6% | $45.71 | $35.17 | — | COM | 48205A109 |
| — | CLOVIS ONCOLOGY INC | 100,000 | $6.8M | 1.6% | $68.00 | $68.00 | — | COM | 189464100 |
| — | LA JOLLA PHARMACEUTICAL CO | 200,000 | $6.436M | 1.5% | $32.18 | $32.18 | — | COM PAR $.0001 2 | 503459604 |
| — | ARRAY BIOPHARMA INC | 500,000 | $6.4M | 1.5% | $12.80 | $12.80 | — | COM | 04269X105 |
| — | OBSEVA SA | 617,100 | $6.023M | 1.4% | $9.76 | $9.76 | — | COM | H5861P103 |
| — | AIMMUNE THERAPEUTICS INC | 158,200 | $5.983M | 1.4% | $37.82 | $20.56 | — | COM | 00900T107 |
| — | HORIZON PHARMA PLC | 400,000 | $5.84M | 1.4% | $14.60 | $14.60 | — | SHS | G4617B105 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 185,000 | $4.991M | 1.2% | $26.98 | $26.98 | — | COM | G11196105 |
| INCY | INCYTE CORP | 50,000 | $4.736M | 1.1% | $94.72 * | $119.92 | -12.8% | COM | 45337C102 |
| — | AQUINOX PHARMACEUTICALS INC | 400,000 | $4.704M | 1.1% | $11.76 | $13.70 | — | COM | 03842B101 |
| — | DICERNA PHARMACEUTICALS INC | 500,000 | $4.515M | 1.1% | $9.03 | $9.03 | — | COM | 253031108 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 65,000 | $3.643M | 0.9% | $56.05 * | $36.42 | +43.5% | COM | 450056106 |
| — | SAGE THERAPEUTICS INC | 21,537 | $3.547M | 0.8% | $164.69 | $164.69 | — | COM | 78667J108 |
| CRSP | CRISPR THERAPEUTICS AG | 150,000 | $3.522M | 0.8% | $23.48 * | $19.00 | 0.0% | NAMEN AKT | H17182108 |
| — | INOTEK PHARMACEUTICALS CORP | 1,300,000 | $3.393M | 0.8% | $2.61 | $2.61 | — | COM | 45780V102 |
| NTLA | INTELLIA THERAPEUTICS INC | 175,000 | $3.364M | 0.8% | $19.22 * | $23.09 | 0.0% | COM | 45826J105 |
| — | RIGEL PHARMACEUTICALS INC | 825,000 | $3.201M | 0.8% | $3.88 | $2.62 | — | COM NEW | 766559603 |
| — | NEOS THERAPEUTICS INC | 300,000 | $3.06M | 0.7% | $10.20 | $7.30 | — | COM | 64052L106 |
| — | DERMIRA INC | 100,000 | $2.781M | 0.7% | $27.81 | $27.81 | — | COM | 24983L104 |
| — | KADMON HLDGS INC | 700,000 | $2.534M | 0.6% | $3.62 | $3.35 | — | COM | 48283N106 |
| — | ABLYNX NV | 90,000 | $2.249M | 0.5% | $24.99 | $24.99 | — | SPONSORED ADR | 00372Y105 |
| CPRX | CATALYST PHARMACEUTICALS INC | 550,000 | $2.151M | 0.5% | $3.91 * | $3.30 | 0.0% | COM | 14888U101 |
| — | GENMARK DIAGNOSTICS INC | 500,000 | $2.085M | 0.5% | $4.17 | $12.22 | — | COM | 372309104 |
| EDIT | EDITAS MEDICINE INC | 65,000 | $1.997M | 0.5% | $30.72 * | $25.18 | 0.0% | COM | 28106W103 |
| — | NABRIVA THERAPEUTICS PLC | 200,000 | $1.196M | 0.3% | $5.98 | $7.31 | — | SHS | G63637105 |
| — | CURRENCYSHS BRIT POUND STER | 9,100 | $1.194M | 0.3% | $131.21 | $126.82 | — | BRIT POUND STE | 23129S106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 25,000 | $727K | 0.2% | $29.08 * | $26.40 | 0.0% | COM | 76243J105 |